Emily Kaiser Maharjan, Assistant Managing Editor

Nystagmus can be an intimidating condition, but understanding the treatment options can help patients feel as if they have more control.

Lisa Hornick, OD, MBA, FAAO, chats about her AAOpt presentations, "Dry Eye Jeopardy" and "Sunny with a Chance of Tears of Tears: What's in the Forecast for Ocular Surface Dryness Therapies."

Post-hoc data helps shine light on better understanding what patient demographics are best suited for presbyopia drops.

At AAOpt, Justin Schweitzer, OD, FAAO, and Selina McGee, OD, FAAO, Dipl ABO, discuss the intersection of dry eye and glaucoma.

Ben Bergo, CEO of Visus, shares data from the company's pivotal phase 3 BRIO-1 trial, as well as answers questions about Brimochol PF.

Easy Anyama shares key takeaway points from "Vision care in the age of ChatGPT" and "Advances in AI and diagnosis for BIPOC populations" at Vision Expo West 2023 in Las Vegas.

The Contact Lens Institute and The Vision Council presented a sneak peek of its forthcoming report, “The Culture Calculation: Data-Backed Behaviors for Contact Lens Success,” which will be published in mid-October 2023.

Justin Schweitzer, OD, FAAO, discusses his talk, "Current trends in keratoconus management," at Vision Expo West 2023 in Las Vegas, Nevada.

The course reviews fitting various contact lenses, looks at practice management essentials, and discusses treatment of contact lens complications.

Lyndon Jones, PhD, DSc, FCOptom, FAAO, showcases topics discussed in the Global Contact Lens Forum at Vision Expo West 2023.

OGS has begun its funding season as the organization looks ahead to wrapping up 2023 and kicking off 2024.

Ocuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents.

Luis Rojas, OD, shares his tips and tricks for getting the best fit for multifocal contact lenses, as well as how to leverage custom fittings as a service as a marketing tool.

AAOMC is focusing on new membership growth, diversity, and how they can continue to move the needle in myopia management.

Lotilaner ophthalmic solution 0.25% (Xdemvy) was approved by the FDA in July, making it the first and only approved treatment for Demodex blepharitis.

The AOA joins several industry leaders in taking the pledge to increase opportunities for Black optometrists and students

The 2023 CRU Eye Symposium in Napa Valley brings exciting presentation topics, including the retina and genetic testing.

Dr Selina McGee, OD, FAAO, Dipl ABO, met with Optometry Times to discuss the recent FDA approval of XDEMVY, a treatment for Demodex blepharitis, from Tarsus Pharmaceuticals.

Hear from A. Paul Chous, OD, MA, FAAO, and what to look forward to during the 2023 EyeCon meeting December 1-2 in Sanibel Harbour, FL.

CRU 2023 will cover a host of topics, including a co-led presentation by Drs Deborah Jacobs and Melissa Barnett on the latest advancements in the contact lens field.

Opthea’s lead biologic drug candidate OPT-302, which is under investigation for the treatment of wet AMD, received nonproprietary drug name sozinibercept, which is a critical step in the FDA approval process.

Diana Canto-Sims, OD, sat down with Optometry Times®' assistant managing editor Emily Kaiser to talk about her role on the founding board of Latinos en Optometry (LEO).

Lina T Arango, OD, sat down with Optometry Times®' assistant managing editor Emily Kaiser to talk about her role on the founding board of Latinos en Optometry (LEO).

Learn about the second annual CRU Eye Symposium, the intentions behind the meeting, and what to expect.

Essence Johnson, OD, FAAO, addressed the "State of optometry," at NOA 2023 in Fort Lauderdale, Florida.

At NOA 2023 in Fort Lauderdale, Florida, Rhea Magee, OD, presented a pediatric patient case as part of the Resident Grand Rounds.

Immediate past president of AOSA Easy Anyama speaks on the latest initiatives of the student organization at NOA 2023 in Fort Lauderdale, Florida.

Isa Prude, president of NOSA, speaks on the Diversifying Optometry Initiative at NOA 2023.